Press Releases

Date Title and Summary
Toggle Summary Accuray Introduces the CyberKnife(R) VSI(TM) System
New Capabilities Extend CyberKnife Treatment Options to Include Robotic IMRT SUNNYVALE, Calif. , Nov. 1 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today the introduction of the CyberKnife(®) VSI(TM) System, the latest
Toggle Summary CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology (ASTRO) Annual Meeting
SUNNYVALE, Calif. , Oct. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that 28 CyberKnife-focused abstracts have been accepted as part of the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO),
Toggle Summary Accuray Announces Results for First Quarter Fiscal 2010
SUNNYVALE, Calif. , Oct. 29 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the first quarter of fiscal year 2010, ended September 30, 2009 . For the first quarter of fiscal 2010, Accuray reported
Toggle Summary Accuray's Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
Service Offers Specialized Physicist Support to New and Existing CyberKnife Sites SUNNYVALE, Calif. , Oct. 27 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that 20 percent of the company's U.S.
Toggle Summary Accuray Announces Regionalized Management Strategy for Americas
New Organization Drives Focus on Sales and Revenue Growth SUNNYVALE, Calif., Oct 21, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today plans to establish an America's region thereby establishing regionalized
Toggle Summary Accuray Ranked 155th Fastest Growing Company in North America on Deloitte's 2009 Technology Fast 500(TM)
Attributes its 975 Percent Revenue Growth to Widespread Adoption of the CyberKnife(R) Robotic Radiosurgery System SUNNYVALE, Calif. , Oct. 20 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it ranked 155th in the
Toggle Summary Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
SUNNYVALE, Calif. , Oct. 13 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the Oppenheimer Healthcare Conference in New York City , on Wednesday, November 4, 2009 at 9:40
Toggle Summary Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
SUNNYVALE, Calif. , Oct. 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, will host an Investor and Analyst Meeting in Chicago, Ill. , on Monday, November 2, 2009 at 3:00 p.m. EDT / 12:00 p.m. PDT .
Toggle Summary Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
SUNNYVALE, Calif. , Oct. 7 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its fiscal first quarter of 2010, ended September 30, 2009 , on Thursday, October 29, 2009 after the market closes.
Toggle Summary Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery
Erectile Function Preserved in More Than 80 Percent of Patients SUNNYVALE, Calif., Oct 01, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today publication of results from a study of early stage prostate cancer

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.